These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2518686)

  • 1. Transformation suppressor genes.
    Noda M; Kitayama H; Kanazawa S; Murata S; Matsuzaki T; Ikawa Y
    Princess Takamatsu Symp; 1989; 20():233-9. PubMed ID: 2518686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of the K-rev-1 transformation-suppressor gene.
    Kitayama H; Matsuzaki T; Sugimoto Y; Ikawa Y; Noda M
    Environ Health Perspect; 1991 Jun; 93():73-7. PubMed ID: 1773804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis of the Kirsten-ras-revertant 1 gene: potentiation of its tumor suppressor activity by specific point mutations.
    Kitayama H; Matsuzaki T; Ikawa Y; Noda M
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4284-8. PubMed ID: 2112251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
    Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
    Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
    Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
    Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversion and rereversion in ras-transformed cells.
    Marshall CJ
    Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
    [No Abstract]   [Full Text] [Related]  

  • 8. The S29 ribosomal protein increases tumor suppressor activity of K rev-1 gene on v-K ras-transformed NIH3T3 cells.
    Kondoh N; Noda M; Fisher RJ; Schweinfest CW; Papas TS; Kondoh A; Samuel KP; Oikawa T
    Biochim Biophys Acta; 1996 Aug; 1313(1):41-6. PubMed ID: 8781548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ; Austin VN; Zimmer SG; Fisher PB
    Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human cDNAs rap1 and rap2 homologous to the Drosophila gene Dras3 encode proteins closely related to ras in the 'effector' region.
    Pizon V; Chardin P; Lerosey I; Olofsson B; Tavitian A
    Oncogene; 1988 Aug; 3(2):201-4. PubMed ID: 3045729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of amino acid residues required for Ras p21 target activation.
    Marshall MS; Davis LJ; Keys RD; Mosser SD; Hill WS; Scolnick EM; Gibbs JB
    Mol Cell Biol; 1991 Aug; 11(8):3997-4004. PubMed ID: 1906576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of GTPases and GTPase regulatory proteins in oncogenesis.
    Grunicke HH; Maly K
    Crit Rev Oncog; 1993; 4(4):389-402. PubMed ID: 8353139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C; Akiyama N; Matsuzaki T; Takai S; Kitayama H; Noda M
    Oncogene; 1996 May; 12(10):2137-46. PubMed ID: 8668339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cDNA clone with anti-oncogene activity.
    Liu DG; Wang D; Chen ZZ; Li ZP; Makoto N; Yoji I
    Sci China B; 1992 Jul; 35(7):822-33. PubMed ID: 1449605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of human Krev-1 gene in lungs of transgenic mice and subsequent reduction in multiplicity of ethyl carbamate-induced lung adenomas.
    Damak S; Harnboonsong Y; George PM; Bullock DW
    Mol Carcinog; 1996 Oct; 17(2):84-91. PubMed ID: 8890957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral transduction and oncogenic selection of a cDNA encoding Dbs, a homolog of the Dbl guanine nucleotide exchange factor.
    Whitehead I; Kirk H; Kay R
    Oncogene; 1995 Feb; 10(4):713-21. PubMed ID: 7862449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Saccharomyces cerevisiae gene product SDC25 C-domain functions as an oncoprotein in NIH3T3 cells.
    Barlat I; Schweighoffer F; Chevallier-Multon MC; Duchesne M; Fath I; Landais D; Jacquet M; Tocque B
    Oncogene; 1993 Jan; 8(1):215-8. PubMed ID: 7999142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flat revertants derived from Kirsten murine sarcoma virus-transformed cells produce transforming growth factors.
    Salomon DS; Zwiebel JA; Noda M; Bassin RH
    J Cell Physiol; 1984 Oct; 121(1):22-30. PubMed ID: 6090475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RalGDS-like factor (Rlf) is a novel Ras and Rap 1A-associating protein.
    Wolthuis RM; Bauer B; van 't Veer LJ; de Vries-Smits AM; Cool RH; Spaargaren M; Wittinghofer A; Burgering BM; Bos JL
    Oncogene; 1996 Jul; 13(2):353-62. PubMed ID: 8710374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid cell transformation requires the expression of the HMGA1 proteins.
    Berlingieri MT; Pierantoni GM; Giancotti V; Santoro M; Fusco A
    Oncogene; 2002 May; 21(19):2971-80. PubMed ID: 12082527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.